Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
AstraZeneca PLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
PR-Inside.com
2009-11-10 02:35:02 - in more than 100 countries throughout the world. It holds 17 research and development sites in eight countries as well as 26 manufacturing plants in 18 countries. Full Article at PR-Inside.com
-
Debate about the climate protection bills currently before Congress has largely centered on their potential costs to business and consumers. Full Article at Sustainable Industries
-
David Brennan, Chief Executive Officer of drug maker AstraZeneca leaves the Marriot hotel in London after its Annual General Meeting, Thursday, April 30, 2009. AstraZeneca Thursday have posted a 42 percent rise in first quarter net profit. View Photo »
-
PARP inhibitors, which include Sanofi-Aventis's BSI-201 and AstraZeneca's olaparib, could dramatically improve prognoses for the woefully underserved patient subgroups with DNA-repair-deficient tumors
SOURCE: News-Medical.net -
You can subscribe to FREE Stock News, to keep yourself updated on the latest in Stock Market by visiting http://www.wepickpennystocks.com AstraZeneca plc (ADR) (NYSE:AZN) jumped 1.82% to $45.80 on a volume of 400K shares after the company was... Full Article at TransWorldNews
-
Keefe Bruyette upgraded Blackstone Group (BX) to outperform from market perform following the company's Q3 results and maintains an $18.50 price target on shares. Full Article at Blogging Stocks
-
AZN) from Neutral to Underweight. To see more analyst ratings on AZN Click Here. Full Article at Street Insider
-
File picture of a signboard of Anglo-Swedish pharmaceutical company AstraZeneca pictured in Macclesfield in northwest England, on November 20, 2008. View Photo »
-
AstraZeneca is proud to continue its longstanding support of the gastroenterology community by helping bring ACG members together in this unique and creative way
SOURCE: Street Insider -
-
MADRID -- U.K. pharmaceutical group AstraZeneca was upgraded to buy from hold on Monday at Royal Bank of Scotland, which cited potential for strong cash flow generation. Full Article at FOX Business
-
MADRID (MarketWatch) -- U.K. pharmaceutical group AstraZeneca /quotes/comstock/13*!azn/quotes/nls/azn (AZN 44.98, +0.05, +0.11%) /quotes/comstock/23s!a:azn (UK:AZN 2,718, +21.00, +0.78%) was upgraded to buy from hold on Monday at Royal Bank of... Full Article at MarketWatch
About AstraZeneca PLC
Wikipedia
There are no results for this module. Edit this module to change the search term used to query Wikipedia
Related Photos
prev
next
-
AP Photo
David Brennan, Chief Executive Officer of drug maker AstraZeneca leaves the Marriot hotel in London after its Annual General Meeting, Thursday, April 30, 2009. AstraZeneca Thursday have posted a 42 percent rise in first quarter net profit.
View Photo » -
Getty Images
File picture of a signboard of Anglo-Swedish pharmaceutical company AstraZeneca pictured in Macclesfield in northwest England, on November 20, 2008.
View Photo » -
Getty Images
A general view of Anglo-Swedish pharmaceutical company AstraZeneca is pictured in Macclesfield in northwest England, on November 20, 2008. Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday it will slash 1,400 jobs by 2013 as it shuts factories in Belgium, Spain and Sweden.
View Photo » -
Getty Images
A signboard of Anglo-Swedish pharmaceutical company AstraZeneca is pictured in Macclesfield in northwest England, on November 20, 2008. Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday it will slash 1,400 jobs by 2013 as it shuts factories in Belgium, Spain and Sweden.
View Photo » -
Getty Images
Signboards of Anglo-Swedish pharmaceutical company AstraZeneca are pictured in Macclesfield in northwest England, on November 20, 2008. Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday it will slash 1,400 jobs by 2013 as it shuts factories in Belgium, Spain and Sweden.
View Photo » -
Getty Images
A signboard of Anglo-Swedish pharmaceutical company AstraZeneca is pictured in Macclesfield in northwest England, on November 20, 2008. Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday it will slash 1,400 jobs by 2013 as it shuts factories in Belgium, Spain and Sweden.
View Photo » -
Getty Images
A general view of Anglo-Swedish pharmaceutical company AstraZeneca is pictured in Macclesfield in northwest England, on November 20, 2008. Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday it will slash 1,400 jobs by 2013 as it shuts factories in Belgium, Spain and Sweden.
View Photo » -
AP Photo
FILE - In this Jan. 29, 2009 file photo, reflections are seen on a sign outside the global headquarters of AstraZeneca in London.
View Photo » -
AP Photo
FILE -- In a Jan. 29, 2009 file photo reflections are seen in the sign on the global headquarters of AstraZeneca in London.
View Photo » -
AP Photo
Reflections are seen in the sign on the global headquarters of Astra Zeneca in London, Thursday, Jan. 29, 2009.
View Photo »
Getty Images
File picture of a signboard of Anglo-Swedish pharmaceutical company AstraZeneca pictured in Macclesfield in northwest England, on November 20, 2008.
View Photo »
